119 related articles for article (PubMed ID: 36435048)
1. Risk of venous thromboembolism and major bleeding in the clinical course of osteosarcoma and Ewing sarcoma.
Kaptein FHJ; Stals MAM; Evenhuis RE; Gelderblom H; Huisman MV; Karis DSA; Noten RWD; Cannegieter SC; Speetjens FM; Verschoor AJ; Versteeg HH; van de Sande MAJ; Klok FA
Thromb Res; 2023 Jan; 221():19-25. PubMed ID: 36435048
[TBL] [Abstract][Full Text] [Related]
2. Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma.
Kaptein FHJ; Stals MAM; Kapteijn MY; Cannegieter SC; Dirven L; van Duinen SG; van Eijk R; Huisman MV; Klaase EE; Taphoorn MJB; Versteeg HH; Buijs JT; Koekkoek JAF; Klok FA
J Thromb Haemost; 2022 Jul; 20(7):1665-1673. PubMed ID: 35460331
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
4. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
[TBL] [Abstract][Full Text] [Related]
5. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
[No Abstract] [Full Text] [Related]
6. 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.
Gaston LL; Di Bella C; Slavin J; Hicks RJ; Choong PF
Skeletal Radiol; 2011 Aug; 40(8):1007-15. PubMed ID: 21298431
[TBL] [Abstract][Full Text] [Related]
7. Incidence of bleeding and thromboembolism and impact on overall survival in adult patients with hemophagocytic lymphohistiocytosis: A 20-year provincial retrospective cohort study.
Croden J; Bilston L; Taparia M; Grossman J; Sun HL
J Thromb Haemost; 2022 Mar; 20(3):671-683. PubMed ID: 34856055
[TBL] [Abstract][Full Text] [Related]
8. Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial.
Italiano A; Mir O; Mathoulin-Pelissier S; Penel N; Piperno-Neumann S; Bompas E; Chevreau C; Duffaud F; Entz-Werlé N; Saada E; Ray-Coquard I; Lervat C; Gaspar N; Marec-Berard P; Pacquement H; Wright J; Toulmonde M; Bessede A; Crombe A; Kind M; Bellera C; Blay JY
Lancet Oncol; 2020 Mar; 21(3):446-455. PubMed ID: 32078813
[TBL] [Abstract][Full Text] [Related]
9. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
10. Subsequent primary neoplasms among bone sarcoma survivors; increased risks remain after 30 years of follow-up and in the latest treatment era, a nationwide population-based study.
Hesla AC; Discacciati A; Tsagkozis P; Smedby KE
Br J Cancer; 2020 Apr; 122(8):1242-1249. PubMed ID: 32066914
[TBL] [Abstract][Full Text] [Related]
11. Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism.
Ferrazzini E; Méan M; Stalder O; Limacher A; Rodondi N; Aujesky D
Blood Adv; 2023 Jan; 7(2):205-213. PubMed ID: 35381071
[TBL] [Abstract][Full Text] [Related]
12. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
[TBL] [Abstract][Full Text] [Related]
13. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Brown JD; Goodin AJ; Lip GYH; Adams VR
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.
Scharrer S; Primas C; Eichinger S; Tonko S; Kutschera M; Koch R; Blesl A; Reinisch W; Mayer A; Haas T; Feichtenschlager T; Fuchssteiner H; Steiner P; Ludwiczek O; Platzer R; Miehsler W; Tillinger W; Apostol S; Schmid A; Schweiger K; Vogelsang H; Dejaco C; Herkner H; Novacek G;
Inflamm Bowel Dis; 2021 Oct; 27(11):1773-1783. PubMed ID: 33386735
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, Treatment, and Prognosis of Tumor Thrombi in Renal Cell Carcinoma.
Kaptein FHJ; van der Hulle T; Braken SJE; van Gennep EJ; Buijs JT; Burgmans MC; Cannegieter SC; du Chatinier EME; Huisman MV; van Persijn van Meerten EL; Versteeg HH; Pelger RCM; Klok FA
JACC CardioOncol; 2022 Nov; 4(4):522-531. PubMed ID: 36444235
[TBL] [Abstract][Full Text] [Related]
16. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
[TBL] [Abstract][Full Text] [Related]
17. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
19. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Major Bleeding During Anticoagulation Therapy in Cancer-Associated Venous Thromboembolism - From the COMMAND VTE Registry.
Nishimoto Y; Yamashita Y; Kim K; Morimoto T; Saga S; Amano H; Takase T; Hiramori S; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Sato Y; Kimura T;
Circ J; 2020 Oct; 84(11):2006-2014. PubMed ID: 33012736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
